Abstract | CONTEXT: METHODS: RESULTS: Abstract #180 discusses the role of metabolic biomarkers in the early diagnosis of pancreatic cancer among diabetic patients, especially recently diagnosed. Abstract #253 debates metformin as a candidate radiosensitizer for pancreatic cancer, although it fails to reject its null hypothesis. CONCLUSION:
|
Authors | Andre Luiz De Souza, Muhammad Wasif Saif |
Journal | JOP : Journal of the pancreas
(JOP)
Vol. 15
Issue 2
Pg. 118-20
(Mar 10 2014)
ISSN: 1590-8577 [Electronic] Italy |
PMID | 24618432
(Publication Type: Congress)
|
Chemical References |
|
Topics |
- Diabetes Complications
(complications, drug therapy)
- Early Diagnosis
- Humans
- Metformin
(therapeutic use)
- Pancreatic Neoplasms
(diagnosis, drug therapy, epidemiology)
- Risk Factors
- Survival Rate
- Treatment Outcome
|